Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA

NCT05354765 is registered in ClinicalTrials.gov with Institut Curie as lead sponsor.

NCT NCT05354765
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05354765 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploration of Adaptive Antitumoral Immune Cells Through Lymphapheresis in Cancer Patients : ALCYTA
Lead sponsor
Institut Curie
Phase
Not applicable
Overall status
Recruiting
Start date
August 31, 2022
Completion date
September 3, 2027
Enrollment
300 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer, immune system or toxicities suspected